CSL stock pre-market at EUR 112.47: plus 1.22 percent
Published on 10/07/2026 at 08:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CSL stock is at EUR 112.47 pre-market at 8:11 a.m. CEST on October 7, 2026, according to Lang & Schwarz. That is plus 1.22 percent versus the EUR 111.11 prior close at Lang & Schwarz on October 6, 2026.
Pre-market trading
The Lang & Schwarz bid is EUR 111.40 and the ask is EUR 113.54. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of CSL stock.
Prior close
The prior close at Lang & Schwarz was EUR 111.11 on October 6, 2026.
Partnership for lixudebart
In an announcement dated October 5, 2026, CSL said it had entered a global partnership with Alentis to develop and commercialize lixudebart for rare kidney and liver diseases. The announcement said Alentis would receive an initial payment of US$355 million and could receive up to US$1.2 billion in commercial milestones, with global profits to be shared.
